Back to mobile site

Form 15-12G Apogee Therapeutics,

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/14/2026

1. ORCL
2. NVDA
3. SPY
4. SRRK
5. DFTX
6. AZN
7. USO
8. SATL
9. LYNX
10. CGEM

September 14, 2026 6:03 AM EDT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM 15
 
 
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934.
 
Commission File Number 001-41740
 
 
APOGEE THERAPEUTICS, INC.
(Exact name of registrant as specified in its charter)
 
 
c/o AbbVie, Inc.
1 North Waukegan Road
North Chicago, Illinois 60064
(847) 932-7900
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
 
Common Stock, $0.00001 par value per share
(Title of each class of securities covered by this Form)
 
None
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
 
 
   
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:    
Rule 12g-4(a)(1)
  ☒
Rule 12g-4(a)(2)
  ☐
Rule 12h-3(b)(1)(i)
  ☒
Rule 12h-3(b)(1)(ii)
  ☐
Rule 15d-6
  ☐
Rule 15d-22(b)
  ☐
 
Approximate number of holders of record as of the certification or notice date: 1.
 
 
1
 
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, Apogee Therapeutics, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
 
       
Date: September 14, 2026
 
 
 
By:
 
/s/ Scott T. Reents
 
 
 
 
Name:
 
Scott T. Reents
 
 
 
 
Title:
 
President
 
 

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings